» Articles » PMID: 31724223

Ras Inhibits TGF-β-induced KLF5 Acetylation and Transcriptional Complex Assembly Via Regulating SMAD2/3 Phosphorylation in Epithelial Cells

Overview
Journal J Cell Biochem
Date 2019 Nov 15
PMID 31724223
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Acetylated Kruppel-like factor 5 (KLF5) is essential for transforming growth factor-β (TGF-β) to properly regulate gene transcription in the inhibition of cell proliferation and tumor growth. Ras oncogenic signaling can convert TGF-β from a tumor suppressor to a tumor promoter; however, its ability to utilize the KLF5 transcription factor to modulate TGF-β functions is still unknown. Therefore, in this study, we sought to determine whether Ras signaling altered TGF-β-induced KLF5 acetylation and the assembly of the p300-KLF5-SMADs transcriptional complex in gene regulation. Not only did we determine that Ras signaling inhibited TGF-β-induced KLF5 acetylation and interfered with TGF-β function in p15 induction and Myc repression, but also TGF-β-induced SMAD3 C-terminal region phosphorylation was necessary for TGF-β to induce KLF5 acetylation. Moreover, Ras activation further interrupted the interactions amongst p300, KLF5, and SMAD4, as well as the binding of p300-KLF5-SMADs complex onto the TGF-β-responsive promoter elements for both p15 and Myc. These findings suggested that KLF5 mediated the crosstalk between TGF-β and Ras signaling, and that suppression of TGF-β-induced KLF5 acetylation by Ras activation; this altered TGF-β-induced assembly of p300-KLF5-SMADs complex onto gene promoters to convert the function of TGF-β in gene regulation.

Citing Articles

KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI1.

Qu X, Xu C, Yang W, Li Q, Tu S, Gao C Cancer Biomark. 2024; 39(3):231-243.

PMID: 38217587 PMC: 11191462. DOI: 10.3233/CBM-230175.


KLF5 promotes esophageal squamous cell cancer through the transcriptional activation of FGFBP1.

Wang F, Luo M, Cheng Y Med Oncol. 2023; 41(1):17.

PMID: 38087142 PMC: 10716083. DOI: 10.1007/s12032-023-02244-x.


CRISPR screens identify gene targets at breast cancer risk loci.

Tuano N, Beesley J, Manning M, Shi W, Perlaza-Jimenez L, Malaver-Ortega L Genome Biol. 2023; 24(1):59.

PMID: 36991492 PMC: 10053147. DOI: 10.1186/s13059-023-02898-w.


Krüppel-like factors in tumors: Key regulators and therapeutic avenues.

Zhang Y, Yao C, Ju Z, Jiao D, Hu D, Qi L Front Oncol. 2023; 13:1080720.

PMID: 36761967 PMC: 9905823. DOI: 10.3389/fonc.2023.1080720.


Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.

Kong Y, Ren W, Fang H, Shah N, Shi Y, You D Int J Biol Sci. 2022; 18(5):2104-2115.

PMID: 35342356 PMC: 8935240. DOI: 10.7150/ijbs.65322.